M3 Global Enterprieses LLC – Trademark Portfolio

Entity Type: 16

M3 Global Enterprieses LLC holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ROYAL. The owner is based in Beavercreek, OH.

70 Birch Alley, Suite 240

Beavercreek, OH 45440

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ROYAL
ROYAL
Registered 2019

Trademark Classifications

M3 Global Enterprieses LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does M3 Global Enterprieses LLC have?

M3 Global Enterprieses LLC has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does M3 Global Enterprieses LLC file in?

M3 Global Enterprieses LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are M3 Global Enterprieses LLC's most well-known trademarks?

M3 Global Enterprieses LLC's registered trademark portfolio includes well-known marks such as ROYAL. These are among 1 currently registered trademark in the portfolio.

What is M3 Global Enterprieses LLC's trademark registration success rate?

M3 Global Enterprieses LLC has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.